Research graph
References from Real-world outcomes after anifrolumab initiation in systemic lupus erythematosus: a pragmatic treat-to-target analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
10.7326/aitc202006020
10.7326/aitc202006020 · 2020 · External reference
10.55563/clinexprheumatol/m0pi1k
10.55563/clinexprheumatol/m0pi1k · External reference
10.1002/art.34672
10.1002/art.34672 · 2012 · External reference
10.1136/annrheumdis-2013-205171
10.1136/annrheumdis-2013-205171 · 2015 · External reference
10.1016/s2665-9913(24)00121-8
10.1016/s2665-9913(24)00121-8 · 2024 · External reference
10.1136/annrheumdis-2015-207726
10.1136/annrheumdis-2015-207726 · 2016 · External reference
10.1093/rheumatology/kew377
10.1093/rheumatology/kew377 · 2017 · External reference
10.1136/annrheumdis-2017-211613
10.1136/annrheumdis-2017-211613 · 2018 · External reference
10.1136/annrheumdis-2013-205139
10.1136/annrheumdis-2013-205139 · 2014 · External reference
10.1016/j.rdc.2019.07.004
10.1016/j.rdc.2019.07.004 · 2019 · External reference
10.1002/acr.25690
10.1002/acr.25690 · 2026 · External reference
10.1136/ard-2023-224762
10.1136/ard-2023-224762 · 2024 · External reference
10.1016/s2665-9913(19)30076-1
10.1016/s2665-9913(19)30076-1 · 2019 · External reference
10.1056/nejmoa1912196
10.1056/nejmoa1912196 · 2020 · External reference
10.1016/j.ard.2025.01.016
10.1016/j.ard.2025.01.016 · 2025 · External reference
10.55563/clinexprheumatol/728zl6
10.55563/clinexprheumatol/728zl6 · 2026 · External reference
10.3899/jrheum.2024-0053
10.3899/jrheum.2024-0053 · 2024 · External reference
10.1136/ard-2022-222748
10.1136/ard-2022-222748 · 2023 · External reference
10.1136/lupus-2021-000538
10.1136/lupus-2021-000538 · 2021 · External reference
